Mubritinib (TAK 165): Decoding Its Dual Role in HER2 and ...
2026-01-20
Explore the advanced mechanisms of Mubritinib (TAK 165), a selective HER2 inhibitor, and its emerging role in mitochondrial complex I inhibition. Gain unique insights into its implications for HER2-driven cancer research and targeted therapy innovation.